You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)附屬訂立有關成立基金合夥協議
阿思達克 05-19 10:03
復星醫藥(02196.HK)公布,附屬公司寧波復瀛及蘇州星晨與復星高科技及其他投資人簽訂蘇州基金合夥協議,內容有關成立蘇州基金。

根據蘇州基金合夥協議,蘇州基金計劃募集資金規模將為10億元人民幣(下同),首輪擬募集資金總額約8.53億元中:蘇州星晨作為普通合夥人,擬以現金出資1,000萬元、寧波復瀛作為有限合夥人擬以現金出資1.92億元、復星高科技作為有限合夥人擬以現金出資1.28億元、其他投資人均作為有限合夥人擬以現金出資合計約5.23億元。

另外,公司附屬公司寧波復瀛、天津星耀及天津星海與復星高科技及其他投資人簽訂天津基金合夥協議,內容有關成立天津基金。

根據天津基金合夥協議,天津基金計劃募集規模將為5億元,其中天津星耀作為普通合夥人擬以現金出資500萬元、寧波復瀛作為有限合夥人擬以現金出資8,000萬元、天津星海作為有限合夥人擬以現金出資1,000萬元、復星高科技作為有限合夥人擬以現金出資7,000萬元、其他投資人均作為有限合夥人,擬以現金出資合計3.35億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account